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Regulation of Human Epidermal Keratinocyte
Differentiation by the Vitamin D Receptor and
its Coactivators DRIP205, SRC2, and SRC3
Nathaniel P. Hawker1, Sally D. Pennypacker1, Sandra M. Chang1 and Daniel D. Bikle1
It has long been known that the active metabolite of vitamin D, 1,25 dihydroxyvitamin D3, stimulates
differentiation and inhibits proliferation in epidermal keratinocytes through interaction with the vitamin D
receptor (VDR). VDR functions through the coordinate binding of vitamin D response elements in the DNA and
specific coactivator proteins which help to initiate transcription. It was recently observed that VDR binds to two
major coactivator complexes, DRIP (VDR-interacting protein) and SRC (steroid receptor coactivator), during
keratinocyte differentiation. To determine the role of VDR and its coactivators in mediating keratinocyte
differentiation, we developed an adenoviral system to knock down, or in the case of VDR, overexpress these
genes. In order to study all stages of keratinocyte development, we employed an advanced differentiated
normal human keratinocyte culture system that produces a multilayer phenotype similar to that of normal skin.
These studies have shown that VDR, DRIP, and SRC are all required for promotion of both early and late
keratinocyte differentiation. Additionally, each individual differentiation marker that was assayed has a different
specificity for the coactivators that regulate its expression.
Journal of Investigative Dermatology (2007) 127, 874–880. doi:10.1038/sj.jid.5700624; published online 2 November 2006
INTRODUCTION
The genomic effects of the active metabolite of vitamin D,
1,25 dihydroxyvitamin D3 (1,25(OH)2D3), are mediated by its
nuclear hormone receptor, vitamin D receptor (VDR). VDR
belongs to the superfamily of steroid hormone receptors and
regulates gene expression as a heterodimer with the retinoid
X receptor. Binding of 1,25(OH)2D3 to VDR modulates
transcription of target genes through binding of VDR to
specific vitamin D response elements in the promoter of
target genes, resulting in the inhibition of proliferation and
stimulation of differentiation of epidermal keratinocytes
(reviewed by Bikle, 2004; Dusso et al., 2005). A number of
coactivators critical for VDR-mediated transcription have
recently been discovered. These coactivators interact with
VDR to form a complex, which activates transcription
presumably by bridging the vitamin D response element to
an initiation complex and/or by increasing accessibility to the
transcription start site by modifying chromatin structure. It
has been shown that the VDR binds to two major coactivator
complexes, DRIP (VDR-interacting protein also called
mediator) and SRC (steroid receptor coactivator) sequentially
during keratinocyte differentiation (Oda et al., 2004). This
observation led to the hypothesis that VDR action in normal
keratinocyte differentiation requires the successive transition
from DRIP in proliferating cells to SRC in more differentiated
cells.
Epidermal differentiation requires the sequential regula-
tion of specific genes, as cells move upwards from the basal
layer through the spinous layer, the granular layer, and
terminally differentiate in the cornified layer. As each
successive layer represents a later stage of development,
epidermal keratinocytes provide an excellent model for the
study of epithelial differentiation. In culture, early differentia-
tion events can be initiated by increasing the concentration of
calcium. Calcium alone, however, does not promote devel-
opment of fully differentiated corneocytes. Recently, a
submerged primary human keratinocyte culture system was
developed that was shown to produce an advanced state of
differentiation with a multilayer phenotype including a
cornified layer similar to that of normal epidermis (Uchida
et al., 2001).
One DRIP subunit, DRIP205/TRAP220, directly binds to
VDR and is thought to be the main anchor for the complex to
VDR (Rachez et al., 2000). As SRC2/TIF2/GRIP1/NcoA-2 and
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SRC3/RAC3/pCIP/ACTR/AIB1/TRAM-1 were the SRC mem-
bers shown to bind to VDR in keratinocytes (Oda et al.,
2004), these, in addition to DRIP205, were chosen for further
study. We developed an adenoviral-based expression system,
which knocks down, or in the case of VDR overexpresses,
these genes in order to utilize the advanced normal human
keratinocyte culture (AdvNHKC) system. To determine the
functional outcome of these changes, we observed the effect
on the expression of well-characterized makers of specific
basal, early, intermediate, and late stages of keratinocyte
differentiation. Our results indicate that, in addition to VDR,
both the DRIP and SRC coactivators are required for both
early and late keratinocyte differentiation. Additionally, each
individual differentiation marker that was assayed has a
different specificity for the coactivators that regulate its
expression.
RESULTS
In order to characterize the differentiation state of our
AdvNHKC system, we compared cells grown for 10 days in
AdvNHKC to cells grown 3 days in 0.03 mM calcium. When
grown subconfluently in 0.03 mM calcium, keratinocytes
remained in a proliferating state. The messenger RNA
(mRNA) levels of several well-established markers of specific
stages of keratinocyte differentiation were measured by
quantitative real-time PCR (qPCR) (Table 1). Ten days in
AdvNHKC did not significantly change (P40.05) the basal
keratin K5 and K14 expression compared to proliferating
keratinocytes. However, these cells had a significant increase
(Po0.01) in the early differentiation keratins K1 (131 ) and
K10 (200 ), intermediate markers involucrin (97 ) and
transglutaminase (3.6 ), and late markers loricrin (71 )
and filaggrin (87 ). VDR and DRIP205 expressions were
not significantly changed (P40.05), whereas SRC2 (2.3 )
and SRC3 (2.6 ) were significantly increased (Po0.05)
when grown in AdvNHKC compared to cells grown in
0.03 mM calcium.
Starting with individual, 19-nucleotide short interfering
RNA oligos, we determined the efficiency of knockdown for
each gene of interest (data not shown). The siOligo
sequence with the greatest knockdown for each gene was
cloned into an adenoviral vector, which constitutively
expresses both the short hairpin RNA (shRNA) and a red
fluorescent protein (RFP). We also constructed a full-length
VDR to green fluorescent protein (VDR-GFP) translational
fusion using PCR to add 12 glycine residues between
the two protein domains and constitutively expressed this
construct in an adenoviral genome. We then empirically
determined that the maximum infection rate for the
AdvNHKC system is 100 infectious units/cell. At infection
rates higher than this, cells did not grow as well as
uninfected cells and some cell death occurred. For all
subsequent experiments, an infection rate of 75 infectious
units/cell was used. Control-infected cells expressed
both a constitutive non-silencing shRNA and a constitutive
RFP. Rates of infection were monitored for each experiment
with fluorescence microscopy to ensure consistent
infection rates.
The mRNA levels of viral-targeted genes (Figure 1a) were
measured after 13 days in culture, 3 days in 0.03 mM calcium
followed by 10 days in AdvNHKC, by qPCR. VDR-GFP-
infected cells showed a 50-fold increase in VDR mRNA;
shVDR reduced VDR expression by 55%; shDRIP205 caused
a 65% knockdown; shSRC2 was 53% effective; and shSRC3
caused a 40% knockdown. Interestingly, the impact on
protein levels of shRNA target genes as measured by Western
blot was greater than the impact on mRNA levels (Figure 1b).
VDR protein was reduced by over 70% by shVDR, DRIP205
protein was reduced by over 90% by shDRIP, SRC2 protein
was reduced by over 60% by shSRC2, and SRC3 was reduced
by over 80% by shSRC3.
To show that the VDR-GFP translational fusion was indeed
responsive to 1,25(OH)2D3, we examined cells with confocal
microscopy 3 days after infection and 6 hours after treatment
with 10 nM 1,25(OH)2D3 (Figure 2). We observed that the RFP
expressed in control-infected cells was not affected by
1,25(OH)2D3 treatment. Although not all of the VDR-GFP
protein was translocated into the nucleus (compare Figure
2c–e), a large portion of the VDR-GFP became specifically
localized to the nucleus and in particular to intranuclear loci
Table 1. mRNA levels in proliferating and advanced
differentiated primary human keratinocytes relative
to mitochondrial ribosomal protein L19
154CF medium 0.03 mM
Ca2+ 3 days
Advanced differentiation
medium10 days
K5 246759 251735
K14 79712 122711
K1 0.2270.12 29712
K10 0.2870.19 56720
INV 0.3470.12 3374.0
TGM1 0.8670.57 3.170.4
LOR 0.2870.09 20713
FLG 0.7170.26 62716
VDR 0.08070.010 0.04770.001
DRIP205 0.6770.17 0.5170.01
SRC2 0.2070.05 0.4570.05
SRC3 1.470.4 3.670.2
DRIP205, vitamin D receptor-interacting protein 205; FLG, filaggrin; INV,
involucrin; K1, 5, 10, and 14, keratins 1, 5, 10, and 14; LOR, loricrin;
mRNA, messenger RNA; SRC2 and SRC3, steroid receptor coactivators 2
and 3; TGM, transglutaminase; VDR, vitamin D receptor.
mRNA levels were determined at different stages of differentiation using
qPCR. When grown in 0.03mM Ca2+, cells are proliferating and the
expression of all but the basal markers is relatively low. After 10 days in
advanced differentiation medium, cells have differentiated and formed
multiple layers and although expression of basal keratins K5 and K14
remained unchanged (P40.05), early differentiation markers K1 and K10,
intermediate markers INV and TGM1, and late markers LOR and FLG all
significantly increased (Po0.01). VDR and DRIP205 levels were not
significantly changed (P40.05), whereas expression of SRC2 and SRC3
was significantly increased (Po0.05). Data are shown as the ratio of the
mRNA level of the marker of interest to that of L19 and are expressed as
mean7SEM of three independent experiments.
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following 1,25(OH)2D3 administration (compare Figure
2g–h). This intranuclear loci phenomenon has been observed
using a variety of techniques including immunohistochem-
istry (Barsony et al., 1990), fluorescent-labeled 1,25(OH)2D3
(Barsony et al., 1997), and observation of VDR-GFP fusion
constructs (Racz and Barsony, 1999). These results show that
our VDR-GFP construct was indeed responsive to its
hormone.
Figure 3 summarizes the effect our shRNA and VDR-GFP
overexpression had on differentiation stage marker mRNA
levels after 10 days in AdvNHKC. As expected, there was no
significant effect of any of our constructs on the basal keratins
K5 and K14. Expression of the early differentiation marker K1
was potentiated by VDR overexpression and inhibited by
knockdown of VDR, DRIP205, and SRC3, but not SRC2.
Although the trend of K10 expression was the same as K1,
only shDRIP205 significantly reduced its expression. Changes
in the intermediate differentiation markers involucrin and
transglutaminase were modest, with only shDRIP205 causing
a significant reduction in involucrin expression. Although the
increase of both involucrin and transglutaminase by con-
stitutive VDR expression was intriguing, these changes were
not statistically significant. The most significant changes were
seen in the late differentiation markers loricrin and filaggrin,
which both showed a significant increase with VDR over-
expression and a significant decrease with all of the shRNA
constructs.
We examined the phenotype of our infected AdvNHKC by
embedding and sectioning the tissue in paraffin. Figure 4
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Figure 1. Targeted expression of genes in advanced differentiated
keratinocyes 13 days after infection with virus containing shRNA or
VDR-GFP. Cells were infected and grown for 3 days in 0.03 mM calcium
before transferring into AdvHKC medium for 10 days. (a) Adenovirus
producing shRNA reduces mRNA expression of the target by anywhere
from 40 to 65% even after almost 2 weeks in culture as measured by qPCR.
Conversely, VDR-GFP virus produces 50-fold more VDR mRNA than
control-infected cells. SEM is calculated from measurements of at least
three independent primary keratinocyte cultures. All changes are significantly
different from controls (Po0.05). (b) Western blots confirm an increase in
protein levels of VDR-GFP compared to control-infected cells; all shRNA
constructs achieve a larger reduction of the targeted gene product than at
the mRNA level as measured by densitometry. Actin levels were measured to
ensure equal loading between samples.
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Figure 2. VDR-GFP localization in primary human keratinocytes in response
to 10 nM 1,25(OH)2D3 treatment. (a) Vehicle-treated control-infected cells
constitutively expressing RFP do not show differences with respect to
(b) 1,25(OH)2D3-treated cells. (c, d) Vehicle-treated cells constitutively
expressing VDR-GFP at (c) higher gain to show VDR-GFP throughout the
cytoplasm and (d) lower gain to show that even without 1,25(OH)2D3
application, much of the protein is nuclear localized. (e, f) Cells from the
same primary culture after 6 hours of 1,25(OH)2D3 treatment. We observed
some trafficking in the cytoplasm at (e) higher gain, but at (f) lower gain we
observed VDR-GFP becoming targeted to specific sites within the nucleus.
(g, h) Medial optical sections through nuclei of (g) 6-hour vehicle-treated and
(h) 6-hour 1,25(OH)2D3-treated cells, highlighting the punctate localization of
VDR-GFP in the nucleus after 1,25(OH)2D3 administration. Confocal
images at (a–f)  100 original magnification and (g, h)  400 magnification
of cells grown in 0.03 mM calcium 3 days after infection with virus.
(a–f) Bar¼ 20 mm. (g, h) Bar¼5 mm.
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shows hematoxylin and eosin-stained sections of control-
infected cells compared to those infected with overexpression
and knockdown constructs. Only shSRC2 cultures had a
phenotype consistently different from that of control in that it
was about two times thicker. This effect was observed in
multiple primary cultures. We then examined the impact of
these constructs on one early (K1) and one late (loricrin)
marker by immunohistochemistry. Figure 5 illustrates the
differences in K1 immunolocalization. Control cultures
showed that K1 was expressed suprabasally and its expres-
sion decreased towards the cornified layers. VDR over-
expression markedly increased K1 expression throughout all
cell layers, whereas shVDR decreased it. Infection with
shDRIP205 and shSRC3 both decreased K1 expression.
shSRC2 appeared to have a broader, but less intense
expression pattern. However, when analyzed by qPCR
(Figure 3), mRNA levels in the shSRC2-infected cells
appeared unchanged compared to control. Figure 6 demon-
strates loricrin immunolocalization. Control-infected cells
expressed loricrin only in the outermost cell layers in a
pattern fairly complementary to K1 expression. VDR over-
expression resulted in loricrin expression in a much broader
pattern than control cultures, whereas all of the shRNA
constructs decreased loricrin expression. These results are
consistent with the effects of these constructs on mRNA levels
shown in Figure 3.
DISCUSSION
Using the AdvNHKC model, we produced multilayered
keratinocytes that have a phenotype similar to that of human
skin complete with a basal layer towards the culture plate
surface and a cornified layer towards the culture medium as
illustrated in Figure 4. This phenotype was confirmed by
immunohistochemistry with both an early marker, K1, which
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Figure 3. Expression of markers of specific stages of keratinocyte differentiation in response to targeted changes in gene expression in advanced differentiated
keratinocyes. Cells were infected and grown for 3 days in 0.03 mM calcium before transferring into AdvNHKC medium for 10 days. To assess the effect of VDR
and its coactivators on differentiation, we analyzed mRNA levels of stage specific markers in these keratinocytes by qPCR. These are represented as fold change
relative to control-infected keratinocytes. Basal markers are keratin 5 and keratin 14, early markers are keratin 1 and keratin 10, intermediate markers are
involucrin and transglutaminase, and late markers are loricrin and filaggrin. *Po0.05 and **Po0.01 compared to control. Error bars enclose mean7SEM for
at least three independent experiments.
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is expressed suprabasally, and a late marker, loricrin, which
is expressed only in the outer, more differentiated cell layers.
Our original working model proposed that the DRIP
complex was the major coactivator involved in VDR-
regulated transcription in proliferating keratinocytes. During
the course of differentiation, the DRIP complex is replaced by
an SRC-containing coactivator complex, and this transition is
required for VDR-mediated keratinocyte differentiation. This
model was supported by the observation that VDR binds to
the DRIP complex in nuclear extracts from proliferating
keratinocytes and to the SRC complex in nuclear extracts
from differentiated keratinocytes (Oda et al., 2004). Based on
this hypothesis, we expected DRIP to have a greater role in
promoting early markers like K1 and K10, whereas SRC
would have a greater role in promoting late markers such as
loricrin and filaggrin. Using this as a starting point, we
developed adenoviral tools to test the function of VDR and its
coactivators DRIP205, SRC2, and SRC3 in the AdvNHKC
model. These studies show that our original model is not
sufficient to explain our results in that the impact of our
shRNA constructs was not limited to any one stage of
differentiation.
One major caveat of this line of reasoning is that the DRIP
and SRC coactivator complexes are utilized by a number of
nuclear hormone receptors (reviewed by Edwards, 2000;
Mahajan and Samuels, 2005). This suggests that any effect
that is seen in keratinocytes infected with coactivator shRNA
may not be acting through VDR, but through some other
nuclear hormone receptor or receptors. Be that as it may,
knockdown of either DRIP or SRC significantly reduced the
expression of the early marker K1 and the late markers
loricrin and filaggrin. However, of the intermediate differ-
entiation markers, only involucrin was significantly de-
creased by shDRIP205. This suggests that each gene has a
different requirement for each coactivator that cannot be
generalized into stages of differentiation.
The data from the VDR overexpression and knockdown
studies are easier to interpret as we have complementary
expression patterns for many of the genes analyzed. VDR had
no control over the expression of the basal keratins K5 and
K14. Although VDR and its ligand 1,25(OH)2D3 are known to
regulate keratinocyte proliferation, which would be expected
Control
VDR-GFP
shDRIP205
shSRC3
shVDR
shSRC2
Towards
the medium
Towards the
culture plate
a b
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e f
Figure 4. Hematoxylin and eosin staining of advanced differentiated
keratinocyte cultures. Hematoxylin and eosin stains of 5 mm sections of
paraffin-embedded advanced differentiated keratinocytes infected with
adenovirus show that these cultures develop into a multilayer tissue with
epidermal-like morphology. There is a more isodiametric basal layer, which is
closest to the culture plate surface and progressively more differentiated cells
as one reaches the culture surface where cells produce corneocytes. There
appear to be no obvious differences between control-infected cells and
those infected with the different adenoviral constructs, except that shSRC2
produces tissue that is consistently twice as thick as any other construct.
(a) Control-infected sections. (b–f) Sections infected with the indicated shRNA
constructs. Bar¼ 50mm.
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Figure 5. Keratin 1 immunolocalization in advanced differentiated
keratinocyte cultures. (a) Control sections show that K1 is expressed
maximally surprabasally, and less in the outermost cell layers. Consistent with
qPCR data, (b) VDR-GFP-infected cells produce a much broader expression
pattern of K1 than control. (c) shVDR, (d) shDRIP205, and (f) shSRC3 all
produce less K1 than control, whereas (e) shSRC2 has a broader, but less
intense expression pattern. Bar¼ 50mm.
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Figure 6. Loricrin immunolocalization on advanced differentiated
keratinocyte cultures. (a) Control-infected cells show loricrin staining only in
the outermost cell layers. VDR-GFP-infected cells produce a broader loricrin
expression pattern with more basal cells producing this protein than control.
(b–f) All shRNA constructs produce less loricrin in advanced differentiated
keratinocytes. Bar¼ 50 mm.
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to impact K5 and K14 mRNA levels, in this study these
markers were normalized to expression of the mitochondrial
ribosomal protein gene L19, which would also be impacted
by changes in cell number. The early differentiation
marker K1 is clearly shown to be VDR regulated in that it
had both a significant reduction of expression owing to
shVDR and a significant increase from VDR-GFP. Even
though the results for K10 did not reach statistical signifi-
cance, they showed the same trend as for K1. As described
above, this effect of VDR could be mediated either by
DRIP205 or SRC3, but not by SRC2. The expression of
the intermediate differentiation markers did not significantly
change from alterations in VDR expression, although the
fact that we observed a complementary pattern with a
reduction in transglutaminase expression with shVDR and an
increase with VDR-GFP suggests that this gene may be
VDR-regulated. The genes that were most responsive to
changes in VDR and coactivator expression were the late
markers loricrin and filaggrin, which were both significantly
increased with VDR overexpression and significantly
decreased with all shRNA constructs. These results show
that expression of these genes was tightly controlled both by
VDR and by DRIP205, SRC2, and SRC3. Unfortunately, from
these experiments, we cannot determine which of these
coactivators VDR is utilizing.
As we utilized 10% fetal calf serum in our AdvNHKC
system, there may have been low levels of vitamin D
metabolites present in the keratinocyte cultures, so the ligand
dependency of observed changes in gene expression cannot
be addressed conclusively by these experiments. However, in
previous experiments levels of 25OHD and 1,25(OH)2D3
were at or below the level of detection in fetal calf serum, and
10% fetal calf serum was insufficient to stimulate the
production of 24,25(OH)2D3, a sensitive indicator of
1,25(OH)2D3 action on these cells (Bikle and Gee, 1989).
Additionally, whether these effects were direct or indirect
cannot be determined from these experiments. Future
experiments designed to identify vitamin D response ele-
ments in the genes with significant changes in expression will
allow us to determine whether they are directly regulated by
VDR, and if so, which coactivators are utilized. It is tempting
to speculate that the intranuclear loci seen in the
1,25(OH)2D3-treated VDR-GFP-infected keratinocytes repre-
sent specific VDR/coregulator/vitamin D response element
complexes, but we have no evidence to support this. Future
experiments utilizing fluorescent in situ hybridization and
immunofluorescent techniques could provide insight into this
hypothesis.
In summary, we have demonstrated that adenoviral
infection in combination with the AdvNHKC system is a
useful model for human skin development. This system could
be a useful tool for modeling human disease. For example,
the shSRC2 culture phenotype is hypercellular similar to
psoriatic skin, suggesting that SRC2 could be a future target of
drug treatments. This is also the first work that shows that late
differentiation markers loricrin and filaggrin are indeed
downstream of VDR and the coactivators DRIP205, SRC2,
and SRC3.
MATERIALS AND METHODS
Cell culture
Primary human keratinocytes were isolated from neonatal foreskins
and grown in serum-free 154CF medium (Cascade Biologics,
Portland, OR) as described previously (Pillai et al., 1988). Second-
passage keratinocytes were then plated in 154CF containing 0.03 mM
calcium. For advanced differentiation studies, cells were subse-
quently transferred into medium containing DMEM and Ham F-12,
3:1 vol/vol, containing 1.2 mM calcium and supplemented with 10%
fetal bovine serum, 10 mg/ml insulin, 0.4 mg/ml hydrocortisone, and
50 mg/ml ascorbic acid for 10 days with media changes every other
day (Uchida et al., 2001).
Adenoviral preparation and infection
For each gene, except for SRC3 for which a published sequence was
used (Shang and Brown, 2002), four individual double-stranded
short interfering RNA siOligos (Dharmacon, Lafayette, CO) were
tested, and one was chosen that has both efficient knockdown of
gene expression and fits the manufacturer’s recommendations for
cloning into the RNAi-Ready-pSIREN-DNR-DsRed-Express (BD
Biosciences, Palo Alto, CA) adenovirus vector. This vector allows
for the adenoviral production of an shRNA under the control of the
human U6 promoter and RFP under control of the immediate early
promoter of human cytomegalovirus. Overexpression of VDR was
achieved by PCR cloning of a translational fusion of full-length VDR
to GFP into pDNR-cytomegalovirus (BD Biosciences). Twelve
glycine residues were added between the translational fusion in
order to cause minimal interference between the VDR and GFP
domains, and this construct was sequenced in order to verify that no
mutations had been introduced. These pDNR constructs were then
cloned into appropriate adenoviral acceptor vectors using Cre
recombinase and amplified in HEK293 cells using manufacturer’s
protocols (BD Biosciences).
The target sequences of shRNAs produced from adenoviral
constructs are VDR 50-CCATTGAGGTCATCATGTT-30, DRIP205
50-GTTCAGAGATCATAGGAAT-30, SRC2 50-GGGTGTCATCGACAAG
GAT-30, SRC3 50-AGACTCCTTAGGACCGCTT-30, and the non-
silencing control 50-TGCGTTGCTAGTACCAACT-30.
Primary second-passage human keratinocytes were infected at a
rate of 75 infectious units/cell and grown for 3 days in 154CF
medium containing 0.03 mM calcium. Controls for each experiment
were infected with virus producing both a non-silencing shRNA and
cytomegalovirus-RFP. The cells were then transferred into advanced
differentiation medium for 10 days as described above. To ensure
equal infection within and between experiments, efficiency was
monitored in live cells by fluorescence microscopy on a Zeiss (Jena,
Germany) IM-35 inverted compound microscope.
Confocal microscopy
For subcellular localization of VDR-GFP, cells plated on glass
coverslips were treated with vehicle or 10 nM 1,25(OH)2D3 and
subsequently fixed in 4% paraformaldehyde in phosphate-buffered
saline for 15 minutes. These were then mounted on glass slides using
Gel-Mount (Biomeda, Foster City, CA) and examined with a Leica
(Wetzlar, Germany) TCS NT/SP confocal microscope.
Quantitative real-time PCR
RNA was collected using an RNeasy kit (QIAGEN, Valencia, CA),
and qPCR was performed on cDNA using either TaqMan premixed
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primer probes and reagents from Applied Biosystems (Foster City,
CA) or SYBR Green primers chosen from PrimerBank (Wang and
Seed, 2003). Mitochondrial ribosomal protein L19 was used as a
normalization control for all experiments. Changes in gene expres-
sion were shown relative to the same keratinocytes infected at the
same time with adenovirus producing non-silencing shRNA and
cytomegalovirus-RFP. Statistics were carried out using Student’s
t-test to compare each construct to the control.
Western analysis and immunohistochemistry
Proteins were extracted with 2% SDS, 10 mM Tris (pH 7.5), and
measured by BCA assay from (Pierce, Rockford, IL). Westerns were
run on 7.5% SDS-polyacrylamide gel electrophoresis and blotted in
Tris/glycine with 5% methanol. These were blocked in 5% milk and
probed with appropriate primary antibodies to VDR (D-6) 1/200
dilution and DRIP205 (TRAP220 C-19) 1/200 dilution (Santa Cruz
Biotechnology, Santa Cruz, CA) and SRC2 (BL436) 1/1,000 dilution
and SRC3 (BL438) 1/500 dilution (Bethyl Laboratories, Montgomery,
TX). Secondary horseradish peroxidase-conjugated antibody
(Amersham Biosciences, Piscataway, NJ) was applied at 1/10,000
dilution and visualized on BioMax MR film (KODAK, Rochester, NY)
with a SuperSignal Kit (Pierce).
For immunolocalization, paraffin-embedded tissues were cut in
5mm sections. After deparaffinization and rehydration, the sections
were boiled in 10 mM citrate buffer. Endogenous peroxidase activity
was quenched with 3% hydrogen peroxide in methanol. The
sections were then incubated following the protocol described by
(Perkin-Elmer, Boston, MA) TSA Biotin System. Slides were
incubated with blocking buffer followed by application of appro-
priate primary antibody Keratin 1 (HK1) at 1/3,000 and Loricrin at 1/
1,000 (Covance, Berkeley, CA) overnight at 41C. Sections were
labeled with appropriate biotinylated secondary antibody and then
incubated with streptavidin-horseradish peroxidase. Biotinyl Tyra-
mide Amplification Reagent was then added followed by a second
application of streptavidin-horseradish peroxidase. Visualization of
enzyme activity was revealed with diaminobenzidine substrate.
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